Literature DB >> 30076605

Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab.

Karsten Weller1, Tatevik Ohanyan1, Tomasz Hawro1, André Ellrich1, Gordon Sussman2, Jake Koplowitz2, Ana M Gimenez-Arnau3, Adriane Peveling-Oberhag4, Petra Staubach4, Martin Metz1, Marcus Maurer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30076605     DOI： 10.1111/all.13586

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  16 in total

1.  Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.

Authors:  R Asero; A V Marzano; S Ferrucci; M Lorini; V Carbonelli; M Cugno
Journal:  Clin Exp Immunol       Date:  2020-03-17       Impact factor: 4.330

Review 2.  Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Authors:  Liting He; Wanyu Yi; Xin Huang; Hai Long; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-16       Impact factor: 8.667

3.  IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies.

Authors:  D M Barrios; G S Phillips; A N Geisler; S R Trelles; A Markova; S J Noor; E A Quigley; H C Haliasos; A P Moy; A M Schram; J Bromberg; S A Funt; M H Voss; A Drilon; M D Hellmann; E A Comen; S Narala; A B Patel; M Wetzel; J Y Jung; D Y M Leung; M E Lacouture
Journal:  Ann Oncol       Date:  2021-03-03       Impact factor: 51.769

4.  Anti-TPO IgE Autoantibody in Chronic Urticaria: Is It Clinically Relevant?

Authors:  Bastsetseg Ulambayar; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2019-01       Impact factor: 5.764

5.  Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications.

Authors:  Ilaria Puxeddu; Fiorella Petrelli; Francesca Angelotti; Cristina Croia; Paola Migliorini
Journal:  J Asthma Allergy       Date:  2019-09-20

Review 6.  Critical Points on the Use of Biologicals in Allergic Diseases and Asthma.

Authors:  Ioana Agache; Catalina Cojanu; Alexandru Laculiceanu; Liliana Rogozea
Journal:  Allergy Asthma Immunol Res       Date:  2020-01       Impact factor: 5.764

Review 7.  EUFOREA consensus on biologics for CRSwNP with or without asthma.

Authors:  Wytske J Fokkens; Valerie Lund; Claus Bachert; Joaquim Mullol; Leif Bjermer; Jean Bousquet; Giorgio W Canonica; Lauren Deneyer; Martin Desrosiers; Zuzana Diamant; Joseph Han; Enrico Heffler; Claire Hopkins; Roger Jankowski; Guy Joos; Andrew Knill; Jivianne Lee; Stella E Lee; Gert Mariën; Benoit Pugin; Brent Senior; Sven F Seys; Peter W Hellings
Journal:  Allergy       Date:  2019-07-15       Impact factor: 13.146

8.  Anxiety, depression, and stress in Korean patients with chronic urticaria.

Authors:  Gil-Soon Choi; Young-Hee Nam; Chan-Sun Park; Mi-Yeong Kim; Eun-Jung Jo; Hye-Kyung Park; Hee-Kyoo Kim
Journal:  Korean J Intern Med       Date:  2020-05-27       Impact factor: 2.884

Review 9.  The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management.

Authors:  Mario Sánchez-Borges; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan Bernstein; Giorgio Walter Canonica; Motohiro Ebisawa; Maximiliano Gomez; Sandra Nora Gonzalez-Diaz; Bryan Martin; Mário Morais-Almeida; Jose Antonio Ortega Martell
Journal:  World Allergy Organ J       Date:  2021-06-01       Impact factor: 4.084

10.  Clinical Characterization of Patients with Chronic Spontaneous Urticaria according to Anti-TPO IgE Levels.

Authors:  Jorge Sánchez; Andres Sánchez; Ricardo Cardona
Journal:  J Immunol Res       Date:  2019-12-07       Impact factor: 4.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.